Abstract Hydroxysteroid 17-beta-dehydrogenase 13 (HSD17B13) is a hepatic lipid droplet-
associated enzyme that is upregulated in patients with non-alcoholic fatty liver disease …

Human genetic studies recently identified an association of SNPs in the 17-β hydroxysteroid
dehydrogenase 13 (HSD17B13) gene with alcoholic and nonalcoholic fatty liver disease …

Abstract 17β-hydroxysteroid dehydrogenase-13 is a hepatocyte-specific, lipid droplet-
associated protein. A common loss-of-function variant of HSD17B13 (rs72613567: TA) …

Abstract 17β-Hydroxysteroid dehydrogenases (HSD17Bs) comprise a large family of 15
members that are mainly involved in sex hormone metabolism. Some HSD17Bs enzymes …

17β-Hydroxysteroid dehydrogenase type 11 (17βHSD11) is mostly localized on the
endoplasmic reticulum (ER) membrane under normal conditions and redistributes to lipid …

Nonalcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease. A
single‐nucleotide polymorphism (SNP), rs6834314, was associated with serum liver …

Nonalcoholic fatty liver disease (NAFLD) has become a worldwide epidemic and a major
public health problem, with a prevalence of approximately 25%. The pathogenesis of …

17β-Hydroxysteroid dehydrogenase (17βHSD) type 13 is identified as a new lipid droplet-
associated protein. 17βHSD type 13 has an N-terminal sequence similar to that of 17βHSD …

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease
worldwide, and there is no specific drug to treat it. Recent results showed that 17-beta …

Nonalcoholic fatty liver disease (NAFLD) is characterized by a massive accumulation of lipid
droplets (LDs). The aim of this study was to determine the function of 17β-hydroxysteroid …